|1.||Murphy, Christopher K: 2 articles (07/2007 - 12/2006)|
|2.||Trampuz, Andrej: 1 article (07/2007)|
|3.||Zimmerli, Werner: 1 article (07/2007)|
|4.||Landmann, Regine: 1 article (07/2007)|
|5.||Widmer, Andreas F: 1 article (07/2007)|
|6.||Rothstein, David M: 1 article (07/2007)|
|7.||Nicolau, David P: 1 article (12/2006)|
|8.||Tessier, Pamela R: 1 article (12/2006)|
|9.||Lee, Su Young: 1 article (12/2006)|
07/01/2007 - "ABI-0043 in combination with a quinolone has the potential for treatment of implant-associated infections caused by susceptible strains of S. "
07/01/2007 - "Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection."
07/01/2007 - "The cure rates of cage-associated infections with rifampin and ABI-0043 administered alone were 46% and 58%, respectively, and increased to 88% and 92% in combination with levofloxacin. "
07/01/2007 - "We compared the efficacy of a novel rifamycin derivative, ABI-0043, with that of rifampin, alone and in combination with levofloxacin, against methicillin-susceptible Staphylococcus aureus ATCC 29213 in a guinea pig tissue-cage infection model. "
|3.||Foreign Bodies (Foreign Body)
|5.||Body Weight (Weight, Body)
|6.||Penicillin G (Benzylpenicillin)